Cargando…
What is the "optimal formula" for donor selection and feces processing for fecal microbiota transplantation in ulcerative colitis?
Autores principales: | Li, Haiyue, Li, Yue, Qian, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278737/ https://www.ncbi.nlm.nih.gov/pubmed/37166218 http://dx.doi.org/10.1097/CM9.0000000000002704 |
Ejemplares similares
-
Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
por: Zhang, Xiaochen, et al.
Publicado: (2022) -
Fecal microbiota transplantation ameliorates active ulcerative colitis
por: Chen, Hui-Ting, et al.
Publicado: (2020) -
An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis
por: Ponce-Alonso, Manuel, et al.
Publicado: (2021) -
The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis
por: Guo, Xiao-He, et al.
Publicado: (2022) -
Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis
por: Zhang, Run-Feng, et al.
Publicado: (2021)